OUP user menu

Cardio NewsWire

Please click here to view the archive of previous Cardio NewsWire stories. Each item is removed from the archive after 90 days.

Nominations requested for eighth edition of Prize

Alcohol and Heart Failure

New Local Associate EHJ Editor: Frank Enseleit

New Local Associate EHJ Editor: Andreas Flammer

 

The 2015 Arrigo Recordati International Prize, call for nominations

The Arrigo Recordati International Prize for Scientific Research has announced the call for nominations for the eighth edition of the award. The International Prize of 100,000 Euros is awarded every two years to a distinguished scientist for his or her commitment and accomplishments in cardiology. In 2015 the Prize will recognize a clinical or basic science investigator who has achieved distinction in the study of secondary prevention and risk reduction strategies for patients with cardiovascular diseases.

The international award was established in 2000 in memory of the Italian pharmaceutical entrepreneur Arrigo Recordati and aims to promote scientific research in the field of cardiovascular disease.

Several International Societies and organizations specializing in Cardiology and Internal Medicine are being invited to nominate candidates that they feel merit the Award. The Prize is open to scientists of all nationalities who work in institutional settings and are not affiliated with a pharmaceutical company or medical device company.

Nominations may only be submitted by an International Society or organization invited to nominate candidates and self-nominations will not be considered. The deadline for nominations for the 2015 award is February 28, 2015. The winner of the Prize will be announced during the European Society of Hypertension (ESH) Annual Meeting in Milan, 12-15 June, 2015.

The 2015 Arrigo Recordati International Prize for Scientific Research Jury is composed of experts who have provided leadership throughout their long careers in the field of secondary prevention and risk reduction strategies for patients with cardiovascular diseases. Jury members for the 2015 edition are: Professor M. John Chapman (Chairman of the Jury), Professor Thomas F. Lüscher and Professor Chris J. Packard.

For more information please visit: www.recordati.com/prize and contact the Organizing Secretariat:
AIM Group International - AIM Congress - Ms Valentina Passalacqua - Phone +39 02 56601.1 - Fax +39 02 56609045 - e-mail: recordatiprize2015@aimgroup.eu 

 

Moderate amounts of alcohol intake linked to reduced risk of heart failure

A large study of nearly 15,000 men and women, just published online in the European Heart Journal [1], shows that drinking up to seven drinks a week in early to middle age is associated with a 20% lower risk of men developing heart failure in the future when compared to people who did not drink at all, and a more modest 16% reduced risk for women.

Dr Alexandra Gonçalves, a research fellow at Brigham and Women’s Hospital, with Dr Scott Solomon, Professor of Medicine at Harvard Medical School and Senior Physician at Brigham and Women’s Hospital, Boston, USA, together with colleagues analysed data from 14,629 people aged between 45-64 years who had been recruited to the Atherosclerosis Risk in Communities Study between 1987 and 1989 in four communities in the USA. They followed the participants for 24-25 years to the end of 2011.

They defined a drink as one that contains 14g of alcohol. During the follow-up period 1271 men and 1237 women developed heart failure. The lowest rate of heart failures occurred in those drinking up to 7 drinks per week.

However, when the researchers looked at death from any cause, there was an increased risk of death of 47% for men and 89% of women who reported consuming 21 or more drinks a week at the start of the study.

Professor Solomon said: “These findings suggest that drinking alcohol in moderation does not contribute to an increased risk of heart failure and may even be protective. No level of alcohol intake was associated with a higher risk of heart failure. However, heavy alcohol use is certainly a risk factor for deaths from any cause.

“The people who were classified as former drinkers at the start of the study had a higher risk of developing heart failure and of death from any cause when compared with abstainers. This could be related to the reasons why they had stopped drinking in the first place, for instance because they had already developed health problems that might have made them more likely to go on to develop heart failure.”

“It is important to bear in mind that our study shows there is an association between drinking moderate amounts of alcohol and a lower risk of heart failure but this does not necessarily mean that moderate alcohol consumption causes the lowered risk, although we did adjust our results to take account, as far as possible, for a variety of other lifestyle factors that could affect a person’s risk,” concluded Professor Solomon.

Notes:
[1] “Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study”, by Alexandra Gonçalves et al. European Heart Journal. doi:10.1093/eurheartj/ehu514

 

Frank Enseleit, new EHJ Local Associate Editor

Frank Enseleit MD FESC joined the EHJ Editorial Board in 2015 as Local Associate Editor. He is Consultant of the Heart failure and transplantation unit in the Department of Cardiology at the University Hospital in Zürich, Switzerland and also works in the coronary care unit and cath lab at the University Hospital. As university lecturer he has teaching responsibilities to medical students and resident physicians in internal medicine and cardiology.

Dr Enseleit received his medical degree from the University of Mainz, Germany, in 1999. He trained in internal medicine and cardiology at the University of Zürich and at the Cantonal Hospital Glarus, both in Switzerland.

Dr Enseleit has published in such peer-reviewed journals as Circulation, the European Heart Journal, the FASEB Journal, American Journal of Cardiology, Europace and Journal of the American College of Cardiology, and he has also authored and published several book chapters and a textbook on cardiovascular disease. He is also a member of the Editorial board of the European Heart Journal and Cardiovascular Medicine and has published several papers on heart failure and heart transplantation.

Dr Enseleit's research interests focus on vascular protection in the pathogenesis of cardiovascular and renal diseases, similarities between cardiovascular and rheumatologic diseases and the cardiovascular safety of cardiovascular and non-cardiovascular drugs.

During recent years he has attended leadership courses focusing on general management, finance, health care economics, human resources and business strategy. Moreover, he is trained in ethical decision-making in the clinical setting.

 

Dr Andreas Flammer joins EHJ Editorial Board

Andreas Flammer MD FESC has joined the EHJ editorial board in 2015 as a new Local Associate Editor. A native Swiss, now a staff physician and lecturer at the University Hospital Zurich studied medicine at the University of Basel. His residency was in Internal Medicine and with his interest in cardiovascular research, he was awarded a Fellowship at the University Hospital of Zurich. He focussed on the study of vascular function in different diseases and treatments and became board certified in cardiology.

He joined the Hospital as a junior staff member of the Heart Failure and Transplantation Unit before moving to the USA for a two-year research Fellowship at the Mayo Clinic in 2010. After this “great experience” he returned as a staff member to the University Heart Center in Zurich and University Lecturer, where he still is today.
His main clinical responsibilities and interests are in heart failure and heart transplantation.Dr Flammer’s research focuses on the vasculature with particular interest on the effects of nutrition and more specifically flavanol-rich foods on blood vessels.

Andreas Flammer has produced more than 60 research articles, reviews and book chapters. In 2014 he was awarded the annual research prize of the Swiss Heart Foundation. He is a member of many national and international societies and a Fellow of the European Society of Cardiology.

Back to top